Proteinase-Activated Receptors, Targets for Kallikrein Signaling

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m513138200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Proteinase-Activated Receptors (PARs) as Targets for Antiplatelet Therapy

Biochemical Society Transactions
Biochemistry
2016English

Basic and Translational Research on Proteinase-Activated Receptors: Implication of Proteinase/Proteinase-Activated Receptor in Gastrointestinal Inflammation

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2008English

Proteinase-Activated Receptors in Fibroproliferative Lung Disease

Thorax
PulmonaryRespiratory Medicine
2013English

Potential of Proteinase-Activated Receptors as a Novel Target for Treatment of Pulmonary Hypertension

Folia Pharmacologica Japonica
Pharmacology
2014English

G-Protein-Coupled Receptors as Signaling Targets for Antiplatelet Therapy

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

Peroxisome-Proliferator-Activated Receptors (PPARs) Are Potential Drug Targets for Cancer Therapy

Oncotarget
Oncology
2017English

Peroxisome Proliferator-Activated Receptors: Targets for the Treatment of Metabolic Illnesses (Review)

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2008English

Proteinase-Activated Receptors (Version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

IUPHAR/BPS Guide to Pharmacology CITE
2019English

Novel Role for Proteinase-Activated Receptor 2 (PAR2) in Membrane Trafficking of Proteinase-Activated Receptor 4 (PAR4)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy